Immune and stromal cell populations via secreted cytokines and growth factors

The phrase Immune and stromal cell populations via secreted cytokines and growth factors refers to the complex signaling network within a tissue microenvironment rather than a single molecular target. This network involves the exchange of chemical messengers—such as interleukins, interferons, transforming growth factor-beta (TGF-beta), and vascular endothelial growth factor (VEGF)—between infiltrating immune cells and resident stromal cells like fibroblasts and endothelial cells. In diseases such as cancer, this crosstalk is often hijacked to create an immunosuppressive and pro-angiogenic environment that promotes tumor growth and metastasis. Therapeutic intervention in this area typically involves using monoclonal antibodies or small molecules to block specific cytokines or their receptors, thereby disrupting the communication that sustains the pathological state. Because it encompasses a broad array of interactions, it is considered a therapeutic strategy or biological context rather than a specific protein target.

Other names

Tumor microenvironment (TME)Stroma-immune crosstalkCytokine-mediated signaling networkParacrine signaling axisInflammatory niche

Modulation of the cellular microenvironment through the inhibition or activation of secreted signaling molecules (cytokines, chemokines, growth factors) and their respective receptors on immune and stromal cells to alter disease progression.